2 unknown, 1 completed, 1 not yet recruiting. 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Not yet recruiting 1 |
| Phase 1 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Vaxine Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine - Chronic Hepatitis b | Phase 1 / Phase 2 | Not yet recruiting | Vaxine Pty Ltd | 40 | 2026-03-01 | 2025-09-22 |
| Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine Spikogen/Covax-19 - COVID-19 | Phase 2 / Phase 3 | Unknown | Vaxine Pty Ltd | 200 | 2022-03-01 | 2024-08-07 |
| Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline placebo - Covid19 | Phase 2 | Completed | Cinnagen | 400 | 2021-05-30 | 2022-10-13 |
| Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax) Delta-inulin, Dose finding comparison - Ant Sting, Immunotherapy | Phase 1 / Phase 2 | Unknown | Central Adelaide Local Health Network Incorporated | 40 | 2016-10-01 | 2020-08-11 |
COVID-19 (2) · Coronavirus Infections (1) · Hepatitis B, Chronic (1)
SARS-CoV-2 recombinant spike protein with delta inulin and CpG-ODN adjuvant vaccine (2) · Engerix-B (1) · Saline Solution (1) · delta inulin (1)
Australia (3) · Iran (1)
Dimitar Sajkov, MD, PhD (1) · Nikolai Petrovsky, MBBS/PhD (1) · Payam Tabarsi, M.D. (1) · Pravin Hissaria, FRACP FRCPA (1)